COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 134 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2018. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $17,000 | -5.6% | 1,150 | 0.0% | 0.01% | -16.7% |
| Q4 2018 | $18,000 | +5.9% | 1,150 | 0.0% | 0.01% | +50.0% |
| Q3 2018 | $17,000 | -19.0% | 1,150 | 0.0% | 0.01% | -20.0% |
| Q2 2018 | $21,000 | -27.6% | 1,150 | 0.0% | 0.01% | -33.3% |
| Q1 2018 | $29,000 | +38.1% | 1,150 | 0.0% | 0.02% | +25.0% |
| Q4 2017 | $21,000 | +75.0% | 1,150 | 0.0% | 0.01% | +71.4% |
| Q3 2017 | $12,000 | -14.3% | 1,150 | 0.0% | 0.01% | -22.2% |
| Q2 2017 | $14,000 | +16.7% | 1,150 | 0.0% | 0.01% | +12.5% |
| Q1 2017 | $12,000 | -33.3% | 1,150 | 0.0% | 0.01% | -46.7% |
| Q4 2016 | $18,000 | -10.0% | 1,150 | 0.0% | 0.02% | -11.8% |
| Q3 2016 | $20,000 | +42.9% | 1,150 | 0.0% | 0.02% | +6.2% |
| Q2 2016 | $14,000 | -33.3% | 1,150 | 0.0% | 0.02% | -33.3% |
| Q1 2016 | $21,000 | +40.0% | 1,150 | +109.1% | 0.02% | +71.4% |
| Q4 2015 | $15,000 | – | 550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,887,332 | $34,840,000 | 5.65% |
| SECTORAL ASSET MANAGEMENT INC | 1,426,862 | $26,340,000 | 3.29% |
| Eventide Asset Management | 2,207,610 | $40,752,000 | 2.12% |
| Rock Springs Capital Management LP | 1,885,729 | $34,811,000 | 1.58% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 460,000 | $8,492,000 | 1.11% |
| Cormorant Asset Management, LP | 300,000 | $5,538,000 | 0.58% |
| HIGHLAND CAPITAL MANAGEMENT LP | 579,234 | $10,693,000 | 0.49% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,389,863 | $25,657,000 | 0.39% |
| NBW CAPITAL LLC | 69,050 | $1,275,000 | 0.34% |
| NEXT CENTURY GROWTH INVESTORS LLC | 144,972 | $2,676,000 | 0.33% |